BlackRock’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$66.9M Buy
18,373,961
+3,041,798
+20% +$11.1M ﹤0.01% 2254
2025
Q1
$29.4M Buy
15,332,163
+234,538
+2% +$450K ﹤0.01% 2683
2024
Q4
$28.7M Sell
15,097,625
-99,582
-0.7% -$189K ﹤0.01% 2778
2024
Q3
$20.1M Buy
15,197,207
+3,558,723
+31% +$4.7M ﹤0.01% 3003
2024
Q2
$11.9M Buy
11,638,484
+9,099,259
+358% +$9.28M ﹤0.01% 3236
2024
Q1
$4.65M Sell
2,539,225
-583,599
-19% -$1.07M ﹤0.01% 3645
2023
Q4
$3.87M Buy
3,122,824
+669,051
+27% +$830K ﹤0.01% 3719
2023
Q3
$2.8M Sell
2,453,773
-283,083
-10% -$323K ﹤0.01% 3823
2023
Q2
$2.5M Buy
2,736,856
+33,333
+1% +$30.5K ﹤0.01% 3878
2023
Q1
$1.52M Sell
2,703,523
-219,022
-7% -$123K ﹤0.01% 4099
2022
Q4
$1.69M Sell
2,922,545
-1,364,411
-32% -$787K ﹤0.01% 4124
2022
Q3
$1.36M Sell
4,286,956
-53,070
-1% -$16.8K ﹤0.01% 4283
2022
Q2
$1.53M Sell
4,340,026
-9,621,514
-69% -$3.39M ﹤0.01% 4274
2022
Q1
$10M Sell
13,961,540
-162,675
-1% -$117K ﹤0.01% 3502
2021
Q4
$31.9M Buy
14,124,215
+71,728
+0.5% +$162K ﹤0.01% 2935
2021
Q3
$40.5M Buy
14,052,487
+877,806
+7% +$2.53M ﹤0.01% 2768
2021
Q2
$49.9M Buy
13,174,681
+805,695
+7% +$3.05M ﹤0.01% 2666
2021
Q1
$41.9M Buy
12,368,986
+971,438
+9% +$3.29M ﹤0.01% 2696
2020
Q4
$31.9M Sell
11,397,548
-346,614
-3% -$970K ﹤0.01% 2694
2020
Q3
$29.5M Buy
11,744,162
+380,299
+3% +$955K ﹤0.01% 2573
2020
Q2
$154M Buy
11,363,863
+1,229,244
+12% +$16.7M 0.01% 1534
2020
Q1
$76.8M Sell
10,134,619
-126,528
-1% -$959K ﹤0.01% 1796
2019
Q4
$64.9M Sell
10,261,147
-319,273
-3% -$2.02M ﹤0.01% 2188
2019
Q3
$41.5M Buy
10,580,420
+352,730
+3% +$1.38M ﹤0.01% 2395
2019
Q2
$49.5M Buy
10,227,690
+1,745,307
+21% +$8.45M ﹤0.01% 2306
2019
Q1
$69.5M Buy
8,482,383
+185,880
+2% +$1.52M ﹤0.01% 2086
2018
Q4
$45.9M Buy
8,296,503
+3,027,657
+57% +$16.7M ﹤0.01% 2286
2018
Q3
$46.5M Buy
5,268,846
+253,811
+5% +$2.24M ﹤0.01% 2396
2018
Q2
$50.1M Buy
5,015,035
+717,328
+17% +$7.16M ﹤0.01% 2339
2018
Q1
$41M Buy
4,297,707
+392,201
+10% +$3.74M ﹤0.01% 2380
2017
Q4
$58.1M Buy
3,905,506
+152,402
+4% +$2.27M ﹤0.01% 2178
2017
Q3
$73.8M Buy
3,753,104
+1,008,497
+37% +$19.8M ﹤0.01% 2027
2017
Q2
$39.4M Buy
2,744,607
+56,535
+2% +$812K ﹤0.01% 2382
2017
Q1
$24.7M Buy
2,688,072
+2,680,345
+34,688% +$24.7M ﹤0.01% 2611
2016
Q4
$80K Buy
7,727
+557
+8% +$5.77K ﹤0.01% 2626
2016
Q3
$65K Buy
7,170
+488
+7% +$4.42K ﹤0.01% 2780
2016
Q2
$50K Buy
6,682
+4,461
+201% +$33.4K ﹤0.01% 2891
2016
Q1
$20K Sell
2,221
-3,288
-60% -$29.6K ﹤0.01% 2785
2015
Q4
$71K Buy
5,509
+239
+5% +$3.08K ﹤0.01% 1856
2015
Q3
$51K Buy
5,270
+5,000
+1,852% +$48.4K ﹤0.01% 1872
2015
Q2
$3K Hold
270
﹤0.01% 3137
2015
Q1
$3K Hold
270
﹤0.01% 3059
2014
Q4
$3K Hold
270
﹤0.01% 3096
2014
Q3
$6K Sell
270
-11,428
-98% -$254K ﹤0.01% 2950
2014
Q2
$326K Buy
+11,698
New +$326K ﹤0.01% 1367